Compounds > celecoxib

celecoxib and angiotensin ii

celecoxib has been researched along with angiotensin ii in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (35.71)29.6817
2010's9 (64.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Hayashi, N; Hori, M; Horimoto, M; Irie, T; Kakiuchi, Y; Kawai, N; Kawano, S; Kimura, A; Komori, M; Murata, H; Nishida, T; Sasaki, Y; Tsuji, S; Tsujii, M; Yasumaru, M1
Gitlin, JM; King, VL; Loftin, CD; Trivedi, DB1
Bishop-Bailey, D; Mitchell, JA; Warner, TD1
Bradley, TJ; Cherney, DZ; Dekker, MG; Hébert, RL; Miller, JA; Nasrallah, R; Scholey, JW; Slorach, C; Sochett, EB1
Adrahtas, A; Bertucci, MC; Cheung, RY; Krum, H; Ma, JY; Wang, BH1
Edwards, DG; Farquhar, WB; Gardner, TJ; Ray, CA; Rose, WC; Stillabower, M; Wenner, MM1
Abdullah, RA; Dewey, WL; Li, C; Li, PL; Lichtman, AH; Poklis, JL; Ritter, JK; Xia, M1
Gitlin, JM; Loftin, CD; Mukherjee, K1
Huwiler, A; Koch, A; Meyer Zu Heringdorf, D; Pfeilschifter, J; Völzke, A1
Aguado, A; Alonso, MJ; Avendaño, MS; Briones, AM; Dixon, DA; Martínez-González, J; Martínez-Revelles, S; Orriols, M; Rodríguez, C; Salaices, M; Zhenyukh, O1
Del Valle-Mondragón, L; Guzmán-Hernández, EA; Ibarra-Barajas, M; Pastelín-Hernández, G; Sánchez-Mendoza, MA; Villalobos-Molina, R1
Li, Y; Ren, L; Tian, D; Zhu, C1
Lei, H; Li, J; Li, L; Liu, H; Yi, J1

Trials

2 trial(s) available for celecoxib and angiotensin ii

ArticleYear
Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus.
    American journal of physiology. Renal physiology, 2008, Volume: 294, Issue:6

    Topics: Adolescent; Adult; Angiotensin II; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Male; Prostaglandins; Proteinuria; Pyrazoles; Renal Circulation; Sex Characteristics; Sulfonamides; Vasoconstrictor Agents; Vasodilation

2008
Celecoxib does not alter cardiovascular and renal function during dietary salt loading.
    Clinical and experimental pharmacology & physiology, 2011, Volume: 38, Issue:8

    Topics: Adult; Aldosterone; Angiotensin II; Blood Pressure; Cardiac Output; Cardiovascular System; Celecoxib; Cyclooxygenase 2 Inhibitors; Humans; Kidney; Kidney Function Tests; Placebos; Prostaglandins; Pyrazoles; Renin; Sodium; Sodium Chloride, Dietary; Sulfonamides

2011

Other Studies

12 other study(ies) available for celecoxib and angiotensin ii

ArticleYear
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Cancer research, 2003, Oct-15, Volume: 63, Issue:20

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cell Division; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Drug Synergism; Enalapril; Humans; Indomethacin; Isoenzymes; Male; Membrane Proteins; Mice; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrazoles; Receptor, IGF Type 1; Sulfonamides

2003
Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:5

    Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Hypercholesterolemia; Male; Mice; Mice, Inbred C57BL; Prostaglandin D2; Pyrazoles; Sulfonamides

2006
COX-2 in cardiovascular disease.
    Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:5

    Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Epoprostenol; Mice; Pyrazoles; Sulfonamides

2006
Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:9

    Topics: Aldosterone; Angiotensin II; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Cardiomegaly; Celecoxib; Collagen; Cyclooxygenase 2 Inhibitors; Female; Fibroblasts; Fibrosis; Heart; Hep G2 Cells; Hepatocytes; Humans; Lactones; Male; Myocardium; Myocytes, Cardiac; Naproxen; Pyrazoles; Rats; Renin-Angiotensin System; Sulfonamides; Sulfones; Vasoconstrictor Agents

2010
Production and actions of the anandamide metabolite prostamide E2 in the renal medulla.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:3

    Topics: Angiotensin II; Animals; Arachidonic Acids; Arterial Pressure; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Endocannabinoids; Glycerides; Kidney Cortex; Kidney Medulla; Kinetics; Lipids; Male; Mice; Mice, Inbred C57BL; Microsomes; Polyunsaturated Alkamides; Potassium; Pyrazoles; Renal Circulation; Sodium; Sulfonamides

2012
Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotype.
    Journal of cardiovascular pharmacology, 2012, Volume: 60, Issue:6

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Rupture; Biomarkers; Celecoxib; Cell Differentiation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phenotype; Pyrazoles; RNA, Messenger; Severity of Illness Index; Sulfonamides; Time Factors

2012
Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells.
    Biochimica et biophysica acta, 2014, Volume: 1841, Issue:1

    Topics: Angiotensin II; Animals; Celecoxib; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Gene Expression Regulation, Enzymologic; Humans; Interleukin-1beta; Lysophospholipids; Male; MAP Kinase Signaling System; Mesangial Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors; Sulfonamides; Up-Regulation; Vasoconstrictor Agents

2014
HuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration.
    British journal of pharmacology, 2015, Volume: 172, Issue:12

    Topics: Angiotensin II; Animals; Aorta; Celecoxib; Cell Movement; Cyclooxygenase 2; Drug Synergism; ELAV-Like Protein 1; Gene Expression Regulation; Humans; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; RNA Stability; RNA, Messenger; Tenascin; Vascular Remodeling

2015
Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.
    Canadian journal of physiology and pharmacology, 2015, Volume: 93, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Captopril; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Gene Expression Regulation; Hypertension, Renal; Kidney Cortex; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Random Allocation; Rats, Wistar; Renin; RNA, Messenger

2015
Demethoxycurcumin Preserves Renovascular Function by Downregulating COX-2 Expression in Hypertension.
    Oxidative medicine and cellular longevity, 2016, Volume: 2016

    Topics: Acetylcholine; Aged; Angiotensin II; Animals; Blood Pressure; Celecoxib; Curcuma; Curcumin; Cyclooxygenase 2; Diarylheptanoids; Down-Regulation; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Male; Microscopy, Fluorescence; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renal Artery; Up-Regulation; Vasoconstriction

2016
Dose-Effect of Irbesartan on Cyclooxygenase-2 and Matrix Metalloproteinase-9 Expression in Rabbit Atherosclerosis.
    Journal of cardiovascular pharmacology, 2018, Volume: 71, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Diseases; Atherosclerosis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Irbesartan; Lipids; Male; Matrix Metalloproteinase 9; NF-kappa B; Plaque, Atherosclerotic; Rabbits; Signal Transduction

2018